RH

Rajeshwar Hiralal Singh

Active Director Director DIN 09603738
DIN 09603738 First appointment May 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value •••• Premium profile

About Rajeshwar Hiralal Singh

Data last updated:

Rajeshwar Hiralal Singh is a Director at Eccentric Clinical Research Private Limited (since 2022). The company operates in Pharma. Eccentric Clinical Research Private Limited reported revenue of ₹47.6 Lakh (FY 2025).

DIN 09603738
Primary Designation Director
Industry Pharma
First Appointment 12 May 2022
Oldest Company Age 4 yrs
Largest company Eccentric Clinical Research Private Limited · ₹47.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 May 20222022₹47.6 Lakh (FY 2025)Active

Board colleagues of Rajeshwar Hiralal Singh

Directorship timeline

Open interactive timeline →
Eccentric Clinical Research Private Limited
Premium access

Shareholding and investment profile for Rajeshwar Hiralal Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajeshwar Hiralal Singh

Rajeshwar Hiralal Singh currently holds 1 directorship: Eccentric Clinical Research Private Limited (Director, since 12 May 2022, revenue ₹47.6 Lakh (FY 2025)).

Rajeshwar Hiralal Singh was first appointed on 12 May 2022 as Director at Eccentric Clinical Research Private Limited.

The current boards of Rajeshwar Hiralal Singh's companies include Amardeep Chimanlal Sharma (Eccentric Clinical Research Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available